Altered formation of DNA in human cells treated with inhibitors of DNA topoisomerase II (etoposide and teniposide).
We have investigated the importance of DNA topoisomerase II for the formation of mammalian DNA replication intermediates. Treatment with the DNA topoisomerase II inhibitor etoposide (teniposide) prevents the formation of large intermediates, such as 10-kilobase DNA, but allows the formation of small intermediates, i.e., Okazaki fragments. In untreated cells, there is a distinct stage in which the 10-kilobase DNA intermediates are joined before the appearance of mature chromatin. We find that pretreatment with etoposide (teniposide) prevents the appearance of this stage. When the protocol is reversed and the cells contain labeled 10-kilobase DNA before exposure to the drugs, one can detect the stage.
Lönn
U
U
Radiumhemmet, Karolinska Hospital, Stockholm, Sweden.
Lönn
S
S
Nylen
U
U
Winblad
G
G
D004261:DNA Replication / Q000187:drug effects*; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000187:drug effects* / Q000302:isolation & purification; D005047:Etoposide / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D008545:Melanoma; D011034:Podophyllotoxin; D013713:Teniposide / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism; D059005:Topoisomerase II Inhibitors; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism*
D004273:DNA, Neoplasm; D059005:Topoisomerase II Inhibitors; D005047:Etoposide; D013713:Teniposide; D011034:Podophyllotoxin; D013936:Thymidine